These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30030254)

  • 1. Unusual cause of sinusitis and cough.
    Aldana G; Jimenez CA; Moran C
    BMJ Case Rep; 2018 Jul; 2018():. PubMed ID: 30030254
    [No Abstract]   [Full Text] [Related]  

  • 2. Remineralization of lytic bone disease in a patient with small lymphocytic lymphoma using ibrutinib.
    Tucker DL; Mihailescu L; Riordan R; Rule S
    Br J Haematol; 2017 Jul; 178(1):153-155. PubMed ID: 27172457
    [No Abstract]   [Full Text] [Related]  

  • 3. Chronic lymphocytic leukemia, autoimmune hemolytic anemia and ibrutinib: a case report and review of the literature.
    Molica S; Levato L; Mirabelli R
    Leuk Lymphoma; 2016; 57(3):735-7. PubMed ID: 26337717
    [No Abstract]   [Full Text] [Related]  

  • 4. Refractory pure red cell aplasia associated with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Goldschmidt N; Rund D
    Leuk Lymphoma; 2017 Feb; 58(2):498-500. PubMed ID: 27756158
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful Treatment of Chronic Lymphocytic Leukemia Multifocal Central Nervous System Involvement with Ibrutinib.
    Christoforidou A; Kapsas G; Bezirgiannidou Z; Papamichos S; Kotsianidis Ι
    Turk J Haematol; 2018 May; 35(2):147-149. PubMed ID: 29391330
    [No Abstract]   [Full Text] [Related]  

  • 6. Real-world results of ibrutinib in relapsed/refractory CLL in France: Early results on a large series of 428 patients.
    Ysebaert L; Aurran-Schleinitz T; Dartigeas C; Dilhuydy MS; Feugier P; Michallet AS; Tournilhac O; Dupuis J; Sinet P; Albrecht C; Cymbalista F
    Am J Hematol; 2017 Aug; 92(8):E166-E168. PubMed ID: 28439916
    [No Abstract]   [Full Text] [Related]  

  • 7. Invasive aspergillosis with pulmonary and central nervous system involvement during ibrutinib therapy for relapsed chronic lymphocytic leukaemia: case report.
    Peri AM; Bisi L; Cappelletti A; Colella E; Verga L; Borella C; Foresti S; Migliorino GM; Gori A; Bandera A
    Clin Microbiol Infect; 2018 Jul; 24(7):785-786. PubMed ID: 29427802
    [No Abstract]   [Full Text] [Related]  

  • 8. High rates of proven invasive fungal disease with the use of ibrutinib monotherapy for relapsed or refractory chronic lymphocytic leukemia.
    Teh BW; Chui W; Handunnetti S; Tam C; Worth LJ; Thursky KA; Slavin MA
    Leuk Lymphoma; 2019 Jun; 60(6):1572-1575. PubMed ID: 30632838
    [No Abstract]   [Full Text] [Related]  

  • 9. Hodgkin Lymphoma Transformation of Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: Chance Association or Therapy-related?
    Sachanas S; Pangalis GA; Moschogiannis M; Yiakoumis X; Koulieris E; Tsirkinidis P; Kalpadakis C; Rontogianni D
    Anticancer Res; 2017 Jun; 37(6):3277-3280. PubMed ID: 28551676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid flare of immune thrombocytopenia after stopping ibrutinib in a patient with chronic lymphocytic leukemia.
    Sato R; Jacob J; Gaballa S
    Leuk Lymphoma; 2018 Jul; 59(7):1738-1741. PubMed ID: 29081253
    [No Abstract]   [Full Text] [Related]  

  • 11. Ibrutinib in very elderly patients with relapsed/refractory chronic lymphocytic leukemia: A real-world experience of 71 patients treated in France: A study from the French Innovative Leukemia Organization (FILO) group.
    Michallet AS; Campidelli A; Lequeu H; Dilhuydy MS; Tournilhac O; Fornecker LM; Dupuis J; Cymbalista F; De Guibert S; Delmer A; Vilque JP; Ghez D; Leblond V; Subtil F; Feugier P; Ysebaert L
    Am J Hematol; 2017 Jun; 92(6):E105-E107. PubMed ID: 28295510
    [No Abstract]   [Full Text] [Related]  

  • 12. [Dyspnea, cough, and pulmonary mass].
    Gutiérrez Zufiaurre JL; García Frade LJ; Gutiérrez Pérez O; López Izquierdo R; Del Campo Matías F; Torres Nieto MA
    Rev Clin Esp; 2002 Jul; 202(7):405-6. PubMed ID: 12139828
    [No Abstract]   [Full Text] [Related]  

  • 13. Rapid onset of hemophagocytic lymphohistiocytosis in a patient with refractory chronic lymphocytic leukemia treated with ibrutinib.
    Poole A; Girard N; Clayton F; Tantravahi SK
    Leuk Lymphoma; 2017 May; 58(5):1258-1261. PubMed ID: 27750463
    [No Abstract]   [Full Text] [Related]  

  • 14. Bilateral cystoid macular edema in a patient with chronic lymphocytic leukemia treated with ibrutinib.
    Saenz-de-Viteri M; Cudrnak T
    Leuk Lymphoma; 2019 Mar; 60(3):842-844. PubMed ID: 30188238
    [No Abstract]   [Full Text] [Related]  

  • 15. Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Quintela A; Sujobert P; Callet-Bauchu E; Salles G; Baseggio L
    Acta Haematol; 2017; 137(1):55-57. PubMed ID: 27960168
    [No Abstract]   [Full Text] [Related]  

  • 16. Optimal First-Line Therapy for Previously Untreated Chronic Lymphocytic Leukemia: The Case for Kinase Inhibitors.
    Lamanna N
    Oncology (Williston Park); 2015 Jun; 29(6):443, 445. PubMed ID: 26091680
    [No Abstract]   [Full Text] [Related]  

  • 17. Progressive multi-focal leucoencephalopathy among ibrutinib-treated persons with chronic lymphocytic leukaemia.
    Bennett CL; Berger JR; Sartor O; Carson KR; Hrushesky WJ; Georgantopoulos P; Raisch DW; Norris LB; Armitage JO
    Br J Haematol; 2018 Jan; 180(2):301-304. PubMed ID: 27649938
    [No Abstract]   [Full Text] [Related]  

  • 18. Response to ibrutinib of refractory life-threatening autoimmune hemolytic anemia occurring in a relapsed chronic lymphocytic leukemia patient with 17p deletion.
    Cavazzini F; Lista E; Quaglia FM; Formigaro L; Cavallari M; Martinelli S; Rigolin GM; Foà R; Cuneo A
    Leuk Lymphoma; 2016 Nov; 57(11):2685-8. PubMed ID: 26999572
    [No Abstract]   [Full Text] [Related]  

  • 19. Ibrutinib for chronic lymphocytic leukemia: international experience from a named patient program.
    Hillmen P; Diels J; Healy N; Iraqi W; Aschan J; Wildgust M
    Haematologica; 2018 May; 103(5):e204-e206. PubMed ID: 29419428
    [No Abstract]   [Full Text] [Related]  

  • 20. Central nervous system immune reconstitution inflammatory syndrome after ibrutinib therapy for Richter transformation.
    Chan KL; Lokan J; Tam CS; Lew TE; Prince HM
    Leuk Lymphoma; 2017 Jan; 58(1):207-210. PubMed ID: 27326828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.